Latest filings (excl ownership)
Latest ownership filings
SC 13G/A
Sigilon Therapeutics, Inc.
14 Feb 24
SC 13G/A
Sana Biotechnology, Inc.
14 Feb 24
4
NOUBAR AFEYAN
15 Sep 23
4
NOUBAR AFEYAN
15 Aug 23
SC 13D/A
Evelo Biosciences, Inc.
13 Jul 23
4
NOUBAR AFEYAN
8 Jun 23
144
Sana Biotechnology, Inc.
7 Jun 23
4
NOUBAR AFEYAN
26 May 23
144/A
Sana Biotechnology, Inc.
24 May 23
144
Sana Biotechnology, Inc.
24 May 23
SC 13D/A
Omega Therapeutics, Inc.
27 Feb 23
SC 13G/A
Codiak BioSciences, Inc.
14 Feb 23
4
NOUBAR AFEYAN
16 Sep 22
SC 13D/A
Evelo Biosciences, Inc.
1 Jun 22
SC 13G
Sana Biotechnology, Inc.
14 Feb 22
SC 13D
Omega Therapeutics, Inc.
6 Aug 21
4
Omega Therapeutics, Inc.
5 Aug 21
3
Omega Therapeutics, Inc.
29 Jul 21
4
NOUBAR AFEYAN
23 Mar 21
SC 13G/A
Denali Therapeutics Inc.
16 Feb 21
SC 13G
Codiak BioSciences, Inc.
16 Feb 21
SC 13G
Sigilon Therapeutics, Inc.
16 Feb 21
4
NOUBAR AFEYAN
10 Feb 21
SC 13D/A
Kaleido Biosciences, Inc.
10 Feb 21
SC 13D/A
Evelo Biosciences, Inc.
4 Feb 21
3
NOUBAR AFEYAN
3 Feb 21
4
NOUBAR AFEYAN
10 Dec 20
3
NOUBAR AFEYAN
3 Dec 20
SC 13D
Foghorn Therapeutics Inc.
29 Oct 20
4
NOUBAR AFEYAN
29 Oct 20
3
NOUBAR AFEYAN
22 Oct 20
4
NOUBAR AFEYAN
20 Oct 20
3
NOUBAR AFEYAN
13 Oct 20
SC 13D/A
Evelo Biosciences, Inc.
1 Jul 20
SC 13D/A
Kaleido Biosciences, Inc.
8 Jun 20
SC 13G/A
Denali Therapeutics Inc.
13 Feb 20
4
NOUBAR AFEYAN
6 Mar 19
SC 13D
Kaleido Biosciences, Inc.
6 Mar 19
3
NOUBAR AFEYAN
27 Feb 19
4
NOUBAR AFEYAN
23 Jul 18